These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12788955)

  • 1. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
    Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
    J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.
    Bardwell AJ; Flatauer LJ; Matsukuma K; Thorner J; Bardwell L
    J Biol Chem; 2001 Mar; 276(13):10374-86. PubMed ID: 11134045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of docking sites in MAPK kinases.
    Bardwell AJ; Frankson E; Bardwell L
    J Biol Chem; 2009 May; 284(19):13165-73. PubMed ID: 19196711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
    Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
    J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2004 Mar; 378(Pt 2):569-77. PubMed ID: 14616089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
    Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1.
    Barr RK; Hopkins RM; Watt PM; Bogoyevitch MA
    J Biol Chem; 2004 Oct; 279(41):43178-89. PubMed ID: 15271995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved docking motif in MAP kinases common to substrates, activators and regulators.
    Tanoue T; Adachi M; Moriguchi T; Nishida E
    Nat Cell Biol; 2000 Feb; 2(2):110-6. PubMed ID: 10655591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
    Grewal S; Molina DM; Bardwell L
    Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
    Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
    J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
    Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
    J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions.
    Shen CP; Tsimberg Y; Salvadore C; Meller E
    BMC Neurosci; 2004 Sep; 5():36. PubMed ID: 15380027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.
    Bardwell AJ; Bardwell L
    J Biol Chem; 2015 Oct; 290(44):26661-74. PubMed ID: 26370088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
    Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
    Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
    Zhang J; Zhou B; Zheng CF; Zhang ZY
    J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes.
    Kayali AG; Austin DA; Webster NJ
    Diabetes; 2000 Nov; 49(11):1783-93. PubMed ID: 11078444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of the signaling molecules for mitogen-activated protein kinase pathways in human, bovine, and rat lenses.
    Li DW; Liu JP; Wang J; Mao YW; Hou LH
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5277-86. PubMed ID: 14638727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.